WallStreetZenWallStreetZen

NASDAQ: TRDA
Entrada Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Entrada Therapeutics revenue was $25.42M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $1.3M, down 19.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TRDA annual revenue was $25.4M, with -87.9% growth year-over-year.

TRDA past revenue growth

How has TRDA's revenue growth performed historically?

Company
-87.94%
Industry
480.24%
Market
90.3%
TRDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TRDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TRDA revenue history

Current Revenue
$25.4M
Current Earnings
-$143.8M
Current Profit Margin
-565.5%

Be the first to know when TRDA announces revenue.

TRDA Revenue History By Year

TRDA Yearly RevenueTRDA RevenueTRDA ChangeTRDA Revenue Growth
2025-12-31$25.42M-$185.36M-87.94%
2024-12-31$210.78M$81.77M+63.38%
2023-12-31$129.01MN/AN/A
2022-12-31$0.00N/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A
2019-12-31$0.00N/AN/A

1 of 1

Entrada Therapeutics Revenue FAQ

What was TRDA's revenue last quarter?

Entrada Therapeutics (NASDAQ: TRDA) reported Q4 2025 revenue of $1.30 million up 96.53% year over year. In the same quarter last year, Entrada Therapeutics's revenue was $37.40 million.

What was Entrada Therapeutics's revenue in 2025?

Entrada Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $25.42 million, a 87.94% decrease year over year.

How much does Entrada Therapeutics make in a day?

Based on Entrada Therapeutics annual revenue for the past five years, TRDA makes an average of $200,118.36 per day.

What was Entrada Therapeutics's annual revenue growth in the past year?

As of Q1 2026, Entrada Therapeutics's revenue has grown -87.94% year over year. This is 568.18 percentage points lower than the US Biotechnology industry revenue growth rate of 480.24%. Entrada Therapeutics's revenue in the past year totaled $25.42 million.

How much does Entrada Therapeutics make in a year?

Entrada Therapeutics's revenue by year for the past five years is:
  • Entrada Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $25.42 million, a 87.94% decrease year over year.
  • Entrada Therapeutics's annual revenue for Dec 31, 2024 was $210.78 million, a 63.38% increase from 2023.
  • Entrada Therapeutics's annual revenue for 2023 was $129.01 million, a Infinity% increase from 2022.
  • Entrada Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Entrada Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.